These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 33809846)
1. Improved Controlled Release and Brain Penetration of the Small Molecule S14 Using PLGA Nanoparticles. Nozal V; Rojas-Prats E; Maestro I; Gil C; Perez DI; Martinez A Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809846 [TBL] [Abstract][Full Text] [Related]
2. Effect of different molecular weight PLGA on flurbiprofen nanoparticles: formulation, characterization, cytotoxicity, and Öztürk AA; Yenilmez E; Şenel B; Kıyan HT; Güven UM Drug Dev Ind Pharm; 2020 Apr; 46(4):682-695. PubMed ID: 32281428 [No Abstract] [Full Text] [Related]
3. PTX-loaded three-layer PLGA/CS/ALG nanoparticle based on layer-by-layer method for cancer therapy. Wang F; Yuan J; Zhang Q; Yang S; Jiang S; Huang C J Biomater Sci Polym Ed; 2018 Sep; 29(13):1566-1578. PubMed ID: 29749303 [TBL] [Abstract][Full Text] [Related]
4. Novel rivaroxaban-loaded poly(lactic-co-glycolic acid)/poloxamer nanoparticles: preparation, physicochemical characterization, in vitro evaluation of time-dependent anticoagulant activity and toxicological profile. Machado ME; de Souza Furtado P; da Costa Bernardes Araújo C; Simon A; de Moraes MC; Rodrigues Pereira da Silva LC; do Carmo FA; Cabral LM; Sathler PC Nanotechnology; 2021 Mar; 32(13):135101. PubMed ID: 33276347 [TBL] [Abstract][Full Text] [Related]
5. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins. Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502 [TBL] [Abstract][Full Text] [Related]
6. Electrospun PLGA membrane incorporated with andrographolide-loaded mesoporous silica nanoparticles for sustained antibacterial wound dressing. Jia Y; Zhang H; Yang S; Xi Z; Tang T; Yin R; Zhang W Nanomedicine (Lond); 2018 Nov; 13(22):2881-2899. PubMed ID: 30427768 [TBL] [Abstract][Full Text] [Related]
7. Preparation of sustained release apremilast-loaded PLGA nanoparticles: in vitro characterization and in vivo pharmacokinetic study in rats. Anwer MK; Mohammad M; Ezzeldin E; Fatima F; Alalaiwe A; Iqbal M Int J Nanomedicine; 2019; 14():1587-1595. PubMed ID: 30880967 [TBL] [Abstract][Full Text] [Related]
8. Axitinib-Loaded Poly(Lactic-Co-Glycolic Acid) Nanoparticles for Age-Related Macular Degeneration: Formulation Development and Narvekar P; Bhatt P; Fnu G; Sutariya V Assay Drug Dev Technol; 2019; 17(4):167-177. PubMed ID: 31184962 [No Abstract] [Full Text] [Related]
9. Microfluidic fabrication and characterization of Sorafenib-loaded lipid-polymer hybrid nanoparticles for controlled drug delivery. Tahir N; Madni A; Li W; Correia A; Khan MM; Rahim MA; Santos HA Int J Pharm; 2020 May; 581():119275. PubMed ID: 32229283 [TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer. Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995 [TBL] [Abstract][Full Text] [Related]
11. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles. Saravanakumar K; Hu X; Shanmugam S; Chelliah R; Sekar P; Oh DH; Vijayakumar S; Kathiresan K; Wang MH Arch Biochem Biophys; 2019 Aug; 671():143-151. PubMed ID: 31283911 [TBL] [Abstract][Full Text] [Related]
12. Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation. Madani F; Esnaashari SS; Bergonzi MC; Webster TJ; Younes HM; Khosravani M; Adabi M Life Sci; 2020 Sep; 256():117943. PubMed ID: 32531377 [TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo evaluation of desmopressin-loaded poly(D,L-lactic-co-glycolic acid) nanoparticles for its potential use in cancer treatment. Chevalier MT; Garona J; Sobol NT; Farina HG; Alonso DF; Álvarez VA Nanomedicine (Lond); 2018 Nov; 13(22):2835-2849. PubMed ID: 30430901 [TBL] [Abstract][Full Text] [Related]
14. Design and in vitro characterization of multistage silicon-PLGA budesonide particles for inflammatory bowel disease. Leonard F; Srinivasan S; Liu X; Collnot EM; Ferrari M; Lehr CM; Godin B Eur J Pharm Biopharm; 2020 Jun; 151():61-72. PubMed ID: 32283213 [TBL] [Abstract][Full Text] [Related]
15. Poly(lactic- Maghrebi S; Joyce P; Jambhrunkar M; Thomas N; Prestidge CA ACS Appl Mater Interfaces; 2020 Feb; 12(7):8030-8039. PubMed ID: 32013379 [TBL] [Abstract][Full Text] [Related]
16. Fabrication of TPGS-Stabilized Liposome-PLGA Hybrid Nanoparticle Via a New Modified Nanoprecipitation Approach: In Vitro and In Vivo Evaluation. Zhang M; He J; Zhang W; Liu J Pharm Res; 2018 Aug; 35(11):199. PubMed ID: 30167890 [TBL] [Abstract][Full Text] [Related]
17. Formulation development and in vitro evaluation of gentamicin sulfate-loaded PLGA nanoparticles based film for the treatment of surgical site infection by Box-Behnken design. Dhal C; Mishra R Drug Dev Ind Pharm; 2019 May; 45(5):805-818. PubMed ID: 30698993 [TBL] [Abstract][Full Text] [Related]
18. Goserelin Acetate Loaded Poloxamer Hydrogel in PLGA Microspheres: Core-Shell Di-Depot Intramuscular Sustained Release Delivery System. Qi P; Bu R; Zhang H; Yin J; Chen J; Zhang A; Gou J; Yin T; Zhang Y; He H; Wang P; Tang X; Wang Y Mol Pharm; 2019 Aug; 16(8):3502-3513. PubMed ID: 31251642 [TBL] [Abstract][Full Text] [Related]
19. Influence of PEGylation on PLGA nanoparticle properties, hydrophobic drug release and interactions with human serum albumin. Samkange T; D'Souza S; Obikeze K; Dube A J Pharm Pharmacol; 2019 Oct; 71(10):1497-1507. PubMed ID: 31385295 [TBL] [Abstract][Full Text] [Related]
20. The Use of an Efficient Microfluidic Mixing System for Generating Stabilized Polymeric Nanoparticles for Controlled Drug Release. Morikawa Y; Tagami T; Hoshikawa A; Ozeki T Biol Pharm Bull; 2018; 41(6):899-907. PubMed ID: 29863078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]